NCT07533942 A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Status NOT_YET_RECRUITING Phase PHASE2
NCT07459634 A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT07434973 Stratification and Treatment in Early Psychosis Study - PROMOTE Status NOT_YET_RECRUITING Phase PHASE3
NCT07377539 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants Status RECRUITING Phase PHASE1
NCT07290985 AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas Status NOT_YET_RECRUITING Phase PHASE2
NCT07282587 Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma Status RECRUITING Phase PHASE2
NCT07233239 A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures Status RECRUITING Phase PHASE1
NCT07192068 Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. Status RECRUITING Phase PHASE2
NCT07176312 Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients Status RECRUITING Phase PHASE2
NCT07153055 Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07102381 A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer Status RECRUITING Phase PHASE2
NCT06961266 A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 Status TERMINATED Phase PHASE1
NCT06924827 A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex Status NOT_YET_RECRUITING Phase PHASE4
NCT06738368 Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors Status RECRUITING Phase PHASE2
NCT06435429 A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Status RECRUITING Phase PHASE3
NCT06282575 Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer Status RECRUITING Phase PHASE3
NCT06261502 Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome Status NOT_YET_RECRUITING Phase PHASE2